Loading
SP
Selectimmune Pharma AB Stock: price and insider trades · Sweden
ISIN SE0012622785SE·
No insider purchase over the last 90 days. The latest, by Marianne Catharina Svanborg, was filed 13 Dec 2020.
Selectimmune Pharma AB: what insiders have been doing
Selectimmune Pharma AB is a listed company. Its directors and officers file their transactions with Finansinspektionen. No insider at Selectimmune Pharma AB has published a filing in the past twelve months. The most recent one dates from 13 December 2020.
Since 2019, the database holds 7 purchases and no sales by insiders of the company.
Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Insider Decl.
17
Thresholds
n/a
Buy Volume
€376,206
7 ops. · all time
Sell Volume
n/a
n/a
Last declaration on 13 December 2020
Declarations17 total
3,000 shares@ SEK 13.510.2% of flowAktieISIN SE0012622785FI:csv-bd7e2de6bc4991b56891
Canonical exit: 9 Mar 2021 (T+90)
50,000 shares@ SEK 13.552.5% of flowAktieISIN SE0012622785FI:csv-6fd99dbe0707f8ebc5de
Canonical exit: 21 May 2020 (T+90)
200,000 shares@ SEK 15.5017.2% of flowAktieISIN SE0012622785FI:csv-2695947f364f13d3dd74
Canonical exit: 6 Feb 2020 (T+90)
1,563 shares@ SEK 15.7028.7% of flowAktieISIN SE0012622785FI:csv-85f5c9d17c1b925dbe4d
Canonical exit: 25 Dec 2019 (T+90)
2,530 shares@ SEK 15.7346.6% of flowAktieISIN SE0012622785FI:csv-5794d568236370ba6523
Canonical exit: 25 Dec 2019 (T+90)
1,337 shares@ SEK 15.7724.7% of flowAktieISIN SE0012622785FI:csv-16e46517806dee1b0ff1
Canonical exit: 25 Dec 2019 (T+90)
50,000 shares0AktieISIN SE0012622785FI:csv-702685e8a0f31f82d0c3
5,200 shares0TeckningsoptionISIN SE0012675601FI:csv-c5e80cc4ae44f2acff55
10,400 shares@ SEK 7.500.3% of flowAktieISIN SE0012622785FI:csv-ce565392e19309c1aa2c
20,000 shares0TeckningsoptionISIN SE0012675601FI:csv-233b55dcb9cdf2b606a9
40,000 shares@ SEK 7.50100.0% of flowAktieISIN SE0012622785FI:csv-aa5207a4654cd8e8a452
6,400 shares0TeckningsoptionISIN SE0012675601FI:csv-afaac6b459c903549550
12,800 shares@ SEK 7.500.3% of flowAktieISIN SE0012622785FI:csv-8ddcba1057bdd04f20ce
Canonical exit: 18 Sept 2019 (T+90)
4,000 shares0TeckningsoptionISIN SE0012675601FI:csv-6df74c1a10cb740c2154
8,000 shares@ SEK 7.50100.0% of flowAktieISIN SE0012622785FI:csv-ea9896c0cb84209d132d
3,599,986 shares@ SEK 7.5096.9% of flowAktieISIN SE0012622785FI:csv-47445046cebca75ad8dd
2,000,000 shares@ SEK 7.5082.6% of flowAktieISIN SE0012622785FI:csv-ccfcfdfc7367a72fb6f8
17 of 17 declarations
About Selectimmune Pharma AB
Selectimmune Pharma AB is a biopharmaceutical company focused on developing immunological treatments. It is listed on the XSTO market.
